Silexion Therapeutics Ltd.
SLXN
Price:
$3.167
Market Cap:
$1.78M
Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem,...[Read more]
Industry
Biotechnology
IPO Date
2024-08-16
Stock Exchange
NASDAQ
Ticker
SLXN
PE Ratio
[0.01]
ROE
[1.22%]
Current Ratio
[2.44]
Dividend Yield
[0%]
Enterprise Value
[2.01M]
Dividend History
The ROE as of December 2025 (TTM) for Silexion Therapeutics Ltd. (SLXN) is 1.22%
According to Silexion Therapeutics Ltd.’s latest financial reports and current stock price. The company's current ROE is 1.22%. This represents a change of -363.26% compared to the average of -462.53% of the last 4 quarters.
Silexion Therapeutics Ltd. (SLXN) Historical ROE (quarterly & annually)
How has SLXN ROE performed in the past?
The mean historical ROE of Silexion Therapeutics Ltd. over the last ten years is -47.43%. The current 1.22% ROE has changed -2667.41% with respect to the historical average. Over the past ten years (40 quarters), SLXN's ROE was at its highest in in the September 2024 quarter at 259.01%. The ROE was at its lowest in in the June 2025 quarter at -2085.83%.
Average
-47.43%
Median
30.15%
Minimum
-413.86%
Maximum
115.30%
Silexion Therapeutics Ltd. (SLXN) ROE by Quarter and Year
Discovering the peaks and valleys of Silexion Therapeutics Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 5.93%
Maximum Annual ROE = 115.30%
Minimum Annual Increase = -4687.89%
Minimum Annual ROE = -413.86%
| Year | ROE | Change |
|---|---|---|
| 2024 | -413.86% | -1396.02% |
| 2023 | 31.93% | 5.93% |
| 2022 | 30.15% | -4687.89% |
| 2021 | -0.66% | -100.57% |
Silexion Therapeutics Ltd. (SLXN) Average ROE
How has SLXN ROE performed in the past?
The current ROE of Silexion Therapeutics Ltd. (SLXN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-117.26%
5-year avg
-47.43%
10-year avg
-47.43%
Silexion Therapeutics Ltd. (SLXN) ROE vs. Peers
How is SLXN’s ROE compared to its peers?
Silexion Therapeutics Ltd.’s ROE is greater than Indaptus Therapeutics, Inc. (-612.63%), greater than Salarius Pharmaceuticals, Inc. (-401.03%), greater than SciSparc Ltd. (-83.38%), greater than Lipella Pharmaceuticals Inc. (-685.24%), greater than Jasper Therapeutics, Inc. (-121.65%), greater than Azitra, Inc. (-516.85%), less than Protagenic Therapeutics, Inc. (336.39%), greater than Onconetix, Inc. (-839.59%), less than Scinai Immunotherapeutics Ltd. (51.65%), greater than Enveric Biosciences, Inc. (-341.49%),
| Company | ROE | Market cap |
|---|---|---|
| -612.63% | $3.75M | |
| -401.03% | $5.10M | |
| -83.38% | $921.38K | |
| -685.24% | $1.43M | |
| -121.65% | $30.23M | |
| -516.85% | $3.74M | |
| 336.39% | $3.24M | |
| -839.59% | $1.68M | |
| 51.65% | $1.41M | |
| -341.49% | $3.65M |
Build a custom stock screener for Silexion Therapeutics Ltd. (SLXN) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Silexion Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Silexion Therapeutics Ltd. (SLXN) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Silexion Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Silexion Therapeutics Ltd.'s ROE?
How is the ROE calculated for Silexion Therapeutics Ltd. (SLXN)?
What is the highest ROE for Silexion Therapeutics Ltd. (SLXN)?
What is the 3-year average ROE for Silexion Therapeutics Ltd. (SLXN)?
What is the 5-year average ROE for Silexion Therapeutics Ltd. (SLXN)?
How does the current ROE for Silexion Therapeutics Ltd. (SLXN) compare to its historical average?